Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations
The Journal of Clinical Pharmacology · 2025
DOI: 10.1002/jcph.6179 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Joseph E Rower und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Asthma, Magnesium Sulfate, Anti-Asthmatic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, Pediatric Acute Care Applied Research Network (PECARN).
Abstract (Originalsprache)
Pediatric asthma exacerbations represent a significant cause of emergency department use and hospitalizations. Despite available treatment options, many children's exacerbations are refractory to standard therapies and require adjunct treatments. The Intravenous Magnesium: Prompt use for Asthma in Children Treated in the Emergency Department study investigated the pharmacology of intravenous magnesium sulfate (IVMg) in treating pediatric asthma exacerbations. Specifically, the objectives of the study included (1) externally validating a previously published population pharmacokinetic model and (2) linking serum magnesium concentrations with outcomes including asthma severity score (efficacy) and hypotension (safety). Data were obtained from 49 children prospectively treated with IVMg (placebo, 50 or 75 mg/kg) after presenting to the pediatric emergency department with an acute asthma exacerbation. Reductions in Pediatric Respiratory Assessment Measure scores were associated with both total and ionized serum magnesium area under the concentration–time curve (AUC 0–2 h ). Despite frequent study‐specific blood pressure monitoring, hypotension was uncommon in IVMg‐treated participants (n = 2/31), and no concentration dependence was observed. The findings signal that IVMg may be an efficacious and safe option for treating moderate–severe pediatric acute asthma exacerbations in the ED. Importantly, this study is the first to suggest a serum exposure target (total serum magnesium AUC 0‐2 h >63.1 mg h/L) reflective of effective IVMg dosing in pediatric acute asthma. While further study in a larger clinical trial is needed to refine and validate this exposure target, these findings support the continued study of IVMg therapy as an adjunct therapeutic option in the setting of pediatric asthma exacerbations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.
- Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA.
- Division of Emergency Medicine, Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, UT, USA.
- Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
- Section of Emergency Medicine, Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH, USA.
- Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
ORCID-Profile: Joseph E Rower
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- Pediatric Acute Care Applied Research Network (PECARN)
- GLACiER-Nationwide Children's Hospital
- SPARC node - Emory University School of Medicine
- CHaMP node- State University of New York at Buffalo
- STELAR - Seattle Children's Hospital
- PRIME-University of California at Davis Medical Center
Zitieren
APA
Rower, J. E., Johnson, M. D., Zorc, J. J., Shihabuddin, B., Dai, M., Barney, B. J., & Finkelstein, Y. (2025). Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.6179
Vancouver
Rower JE, Johnson MD, Zorc JJ, Shihabuddin B, Dai M, Barney BJ, et al. Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.6179
BibTeX
@article{Rower2025,
author = {Rower, Joseph E and Johnson, Michael D and Zorc, Joseph J and Shihabuddin, Bashar and Dai, Mengtao and Barney, Bradley J and Finkelstein, Yaron},
title = {Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations},
journal = {The Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/jcph.6179}
}
EUVIMED